Active Ingredients

Rivaroxaban 2.5, 10, 15, 20mg

Leaflet & registration license

Price: 32.25 L.E/ 1 strip (10 tablets)

Leaflet & registration license

Price: 170 L.E/ 1 strip (10 tablets)

Leaflet & registration license

Price: 130 L.E/ 1 strip (10 tablets)

Leaflet & registration license

Price: 130 L.E/ 1 strip (10 tablets)

Indications

Vaxato is a factor Xa inhibitor indicated:

• To reduce risk of stroke and systemic embolism in non-valvular atrial fibrillation

• For treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) (in pediatrics over 30 Kg and in adults)

• For reduction in the risk of recurrence of DVT or PE

• For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery

• To reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD)

• To reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD.

• For the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticlopidine.